White & Case Antitrust Partners Eric Grannon, Strati Sakellariou-Witt and Adam Acosta, Counsel Charles Moore and Senior Advisor Daniel Sokol will join several panels at the American Bar Association’s 72nd Antitrust Law Spring Meeting. The Spring Meeting is the largest gathering of competition, consumer protection, and data privacy professionals globally, with lawyers, academics, economists, enforcers, journalists, and students from around the world. Each White & Case panelist will speak on separate panels on the first day of the Spring Meeting, Wednesday, April 10, 2024, at the Marriott Marquis Washington, DC.
Eric, Strati, Adam, Charles and Daniel will offer their insights on a variety of topics at the Spring Meeting, covering the most prevalent topics companies face in the shifting landscape of antitrust class actions, enforcement and arbitrations.
Strati Sakellariou-Witt |
From Farm to Table: Dealing with Distributors Strati Sakellariou-Witt will join a panel offering guidance to companies that work closely with distributors. At a time when exchanges of sensitive information and renewed debates on exclusivity agreements and resale price maintenance and most favored nation provisions are at the forefront of potential enforcement actions, the panel will discuss how companies can navigate these issues and how they should regulate their relationship with distributors to respond to these concerns. |
Eric Grannon |
Navigating Global Class Certification Standards Eric Grannon will speak on a panel discussing the evolution and state of antitrust class actions around the world, addressing important recent cases in key jurisdictions, the Representative Actions Directive in the EU, and the use of abuse of dominance theories to support class certification. |
D. Daniel Sokol |
The New, New, Wave: Competition Policy Interrupted? Daniel Sokol will join a panel breaking down how current FTC efforts to transform antitrust policy echo similar attempts in the 70's and 80's. With respect to merger enforcement, the panel will discuss whether current leadership will pursue "competition policy in the broadest sense," or if wide backlash is on the horizon. |
Adam Acosta |
Drug Wars: Pharma Ecosystem Feels Agency Heat Adam Acosta will speak on a panel discussing antitrust scrutiny of the pharmaceutical industry. The panel will offer insights into the FTC's investigation into PBMs, the DOJ’s generic drug criminal investigation, the FTC’s challenge to the Amgen-Horizon deal, and how challenges to excessive pricing in Europe may translate to US antitrust enforcement. |
Charles Moore |
Mass Arbitration Meets Antitrust – and More Charles Moore will join a panel breaking down the shifting landscape in Antitrust arbitrations in the US, Europe and Canada, along with how parties on both sides of a dispute might approach arbitration given the possibility of thousands of claimants initiating claims asserting antitrust violations. |
White & Case means the international legal practice comprising White & Case LLP, a New York State registered limited liability partnership, White & Case LLP, a limited liability partnership incorporated under English law and all other affiliated partnerships, companies and entities.
This article is prepared for the general information of interested persons. It is not, and does not attempt to be, comprehensive in nature. Due to the general nature of its content, it should not be regarded as legal advice.
© 2024 White & Case LLP
